BAM
Blueshift Asset Management’s Thermo Fisher Scientific TMO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $772K | Buy |
1,903
+978
| +106% | +$397K | 0.24% | 105 |
|
|
2025
Q1 | $460K | Buy |
+925
| New | +$460K | 0.18% | 172 |
|
|
2024
Q1 | – | Sell |
-1,368
| Closed | -$726K | – | 372 |
|
|
2023
Q4 | $726K | Buy |
+1,368
| New | +$726K | 0.39% | 72 |
|
|
2023
Q3 | – | Sell |
-1,133
| Closed | -$591K | – | 424 |
|
|
2023
Q2 | $591K | Buy |
+1,133
| New | +$591K | 0.23% | 115 |
|
|
2023
Q1 | – | Sell |
-1,158
| Closed | -$638K | – | 455 |
|
|
2022
Q4 | $638K | Buy |
1,158
+394
| +52% | +$217K | 0.3% | 97 |
|
|
2022
Q3 | $387K | Buy |
+764
| New | +$387K | 0.08% | 343 |
|
|
2022
Q2 | – | Sell |
-483
| Closed | -$285K | – | 998 |
|
|
2022
Q1 | $285K | Sell |
483
-6,051
| -93% | -$3.57M | 0.03% | 631 |
|
|
2021
Q4 | $4.36M | Buy |
6,534
+5,202
| +391% | +$3.47M | 0.38% | 69 |
|
|
2021
Q3 | $761K | Sell |
1,332
-9,691
| -88% | -$5.54M | 0.04% | 494 |
|
|
2021
Q2 | $5.56M | Buy |
11,023
+823
| +8% | +$415K | 0.3% | 90 |
|
|
2021
Q1 | $4.66M | Buy |
10,200
+8,059
| +376% | +$3.68M | 0.48% | 37 |
|
|
2020
Q4 | $997K | Buy |
+2,141
| New | +$997K | 0.12% | 266 |
|
|
2020
Q3 | – | Sell |
-4,879
| Closed | -$1.77M | – | 770 |
|
|
2020
Q2 | $1.77M | Buy |
+4,879
| New | +$1.77M | 0.29% | 109 |
|
|
2020
Q1 | – | Sell |
-2,920
| Closed | -$949K | – | 660 |
|
|
2019
Q4 | $949K | Buy |
+2,920
| New | +$949K | 0.11% | 292 |
|